Impact of Arterial Hypertension on Left Atrial Size and Function

Table 4

Bivariate analysis of LA function.

Variables		LA reservoir impaired		LA conduit impaired		LA pomp impaired
		Effective (%)	value	Effective (%)	value	Effective (%)	value
Age group	40-49	02 (13,33%)	0,94	08 (10%)	N/A	05 (27,77%)	N/A
	50-59	07 (46,66%)		42 (52,5%)		10 (55,55%)
	60-69	05 (33,33%)		22 (27,5%)		02 (11,11%)
	70-79	01 (6,66%)		08 (10%)		01 (5,55%)
Genre	Men	09 (60%)	0,54	50 (62,5%)	0,59	12 (66,66%)	0,29
	Women	06 (40%)		30 (37,5%)		06 (33,33%)
Grade AHT	I	00 (0%)	0,79	03 (3,8%)	N/A	00 (0%)	NA
	II	11 (73,33%)		50 (62,5%)		12 (66,66%)
	III	04 (26,66%)		27 (33,7%)		06 (33,33%)
Diabetes	Yes	08 (53,33%)	0,3	32 (30%)	0,08	09 (50%)	0,37
	No	07 (46,66%)		48 (60%)		09 (50%)
Dyslipidemia	Yes	03 (20%)	0,5	15 (18,8%)	0,1	06 (33,33%)	0,16
	No	12 (80%)		65(81,2%)		12 (66,66%)
Sedentarite	Yes	07 (46,66%)	0,48	32 (30%)	0,16	08 (44,44%)	0,54
	No	08 (53,33%)		48 (60%)		10 (55,55%)
Obesity	Yes	06 (40%)	0,41	32 (30%)	0,015	10 (55,55%)	0,26
	No	09 (60%)		48 (60%)		08 (44,44%)
Smoking	Yes	04 (26,66%)	0,23	14 (17,5%)	0,54	04 (22,22%)	0,36
	No	11 (73,33%)		66 (82,5%)		14 (77,77%)
Coronary heredity	Yes	00 (0%)	0,61	03 (3,8%)	0,5	01 (5,55%)	0,45
	No	15 (100%)		77 (96,2%)		17 (94,44%)
Menopause	Yes	03 (20%)	0,09	06 (7,5%)	0,5	03 (16,66%)	0,15
	No	12 (80%)		74 (92,5%)		15 (83,33%)
CA	Yes	01 (6,66%)	0,14	17 (21,25%)	0,39	00 (0%)	0,012
	No	14 (93,33%)		63 (78,75%)		18 (100%)
ACE	Yes	02 (13,33%)	0,57	08 (10%)	0,19	06 (33,33%)	0,07
	No	13 (86,66%)		72 (90%)		12 (66,66%)
ARAII	Yes	01 (6,66%)	0,59	06 (7,5%)	0,25	01 (5,55%)	0,49
	No	14 (93,33%)		74 (92,5%)		17 (94,44%)
BB	Yes	03 (20%)	0,023	05 (6,25%)	0,31	01 (5,55%)	0,63
	No	12 (80%)		75 (93,75%)		17 (94,44%)
Diastolic dysfunction	I	10 (66,6%)	0,4	46 (57,5%)	N/A	07 (38,88%)	N/A
	Ii	02 (13,33%)		23 (28,75%)		04 (22,22%)
	Iii	00 (0%)		01 (1,25%)		01 (5,55%)
	Undetermined	03 (20%)		10 (12,5%)		06 (33,33%)
LVH	Yes	12 (80%)	0,15	52 (65%)	0,6	14 (77,77%)	0,16
	No	03 (20%)		28 (35%)		04 (22,22%)

CA: calcium antagonists; ACE: angiotensin-converting enzyme; ARAII: angiotensin II receptor antagonists; BB: beta-blockers; N/A: not applicable; LVH: left ventricular hypertrophy.